Clinical Trial Update: Discovery and Validate of Multi-genetic Biomarkers for Capecitabine in Chinese Colorectal Patients

View source ↗

Summary

A clinical trial update describing discovery and validation of multi-genetic biomarkers for capecitabine in Chinese patients with colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer, Capecitabine | Status: UNKNOWN